Achieve Life Sciences (ACHV) Leases (2019 - 2026)
Achieve Life Sciences (ACHV) has disclosed Leases for 8 consecutive years, with $49000.0 as the latest value for Q1 2026.
- Quarterly Leases fell 53.77% to $49000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $49000.0 through Mar 2026, down 53.77% year-over-year, with the annual reading at $64000.0 for FY2025, 46.22% down from the prior year.
- Leases for Q1 2026 was $49000.0 at Achieve Life Sciences, down from $64000.0 in the prior quarter.
- The five-year high for Leases was $123000.0 in Q4 2022, with the low at $18000.0 in Q3 2022.
- Average Leases over 5 years is $69941.2, with a median of $66000.0 recorded in 2023.
- The sharpest move saw Leases crashed 77.22% in 2022, then surged 344.44% in 2023.
- Achieve Life Sciences' Leases stood at $123000.0 in 2022, then tumbled by 46.34% to $66000.0 in 2023, then surged by 80.3% to $119000.0 in 2024, then plummeted by 46.22% to $64000.0 in 2025, then dropped by 23.44% to $49000.0 in 2026.
- Per Business Quant, the three most recent readings for ACHV's Leases are $49000.0 (Q1 2026), $64000.0 (Q4 2025), and $79000.0 (Q3 2025).